Large enterprise employers are re-evaluating corporate health insurance coverage frameworks following a sharp increase in claims for GLP-1 weight-loss medications.
Actuarial Analysis
While long-term cardiovascular benefits are projected to lower future chronic care claims, immediate plan expenses have risen by an average of 8% across self-insured corporate plans.
Formulary Restrictions
Benefits administrators are implementing stricter prior-authorization requirements and lifestyle management program prerequisites to control short-term pharmaceutical spending.